Autonomic nervous system response to L-dopa in patients with advanced Parkinson's disease

Levodopa is the main treatment method for reducing the symptoms of Parkinson's disease. Whereas it reduces the motor symptoms efficiently, its effect on autonomous nervous system is not clear. The information about effect of levodopa on heart rate variability is not coherent between the studies. In this study, ECG of 11 patients with Parkinson's disease was measured during levodopa challenge with pronounced dose of fast release levodopa to ensure the positive drug effect for deep brain stimulation treatment. Heart rate variability analysis was done at three time points, before administration of levodopa, 30 and 60 minutes after administration. After 30 minutes of administration, the HRV parameters show that parasympathetic nervous system activity is decreased and the sympatho-vagal balance is shifted towards sympathetic control. At 60 minutes after administration the parasympathetic nervous system activates slightly and causes a decrease in heart rate.

[1]  M. Breteler,et al.  Epidemiology of Parkinson's disease , 2006, The Lancet Neurology.

[2]  G. Breithardt,et al.  Heart rate variability: standards of measurement, physiological interpretation and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. , 1996 .

[3]  Hakan Widner,et al.  Deep brain stimulation for Parkinson's disease: Patient selection and evaluation , 2002, Movement disorders : official journal of the Movement Disorder Society.

[4]  Mika P. Tarvainen,et al.  An advanced detrending method with application to HRV analysis , 2002, IEEE Transactions on Biomedical Engineering.

[5]  A. Benabid,et al.  Predictors of effective bilateral subthalamic nucleus stimulation for PD , 2002, Neurology.

[6]  A. Lipp,et al.  Cardiovascular effects of levodopa in Parkinson's disease. , 2014, Parkinsonism & related disorders.

[7]  A. Alessandri,et al.  Twenty‐four‐hour heart rate variability to assess autonomic function in Parkinson's disease , 1999, Acta neurologica Scandinavica.

[8]  O. Rascol,et al.  Effects of acute levodopa administration on blood pressure and heart variability in never treated parkinsonians. , 1995, Hypertension research : official journal of the Japanese Society of Hypertension.

[9]  A. Destée,et al.  Heart rate variability and Parkinson’s disease severity , 2003, Journal of Neural Transmission.

[10]  Mika P. Tarvainen,et al.  Kubios HRV - Heart rate variability analysis software , 2014, Comput. Methods Programs Biomed..

[11]  J. Korpelainen,et al.  Levodopa, bromocriptine and selegiline modify cardiovascular responses in Parkinson's disease , 2000, Journal of Neurology.

[12]  H. Nagaraja,et al.  Heart rate variability: origins, methods, and interpretive caveats. , 1997, Psychophysiology.

[13]  D. Calne,et al.  Hypotension Caused by L-Dopa , 1970, British medical journal.

[14]  L. Rumbach,et al.  Impaired cardiovascular autonomic control in newly and long-term-treated patients with Parkinson's disease: involvement of l-dopa therapy , 2004, Autonomic Neuroscience.

[15]  L. Schiffer,et al.  Aromatic amino acids and modification of parkinsonism. , 1967, The New England journal of medicine.